St. Jude CEO: Medtronic’s renal denervation miss doesn’t dampen our spirits

St. Jude CEO: Medtronic's miss doesn't dampen our spirits

St. Jude Medical (NYSE:STJ) CEO Daniel Starks remains steadfast in his pursuit of renal denervation in treatment of hypertension, despite the high-profile clinical trial flop suffered just last week by rival medtech titan Medtronic (NYSE:MDT).

St. Jude will continue with its renal denervation initiatives and Starks still sees the technology as a potential winner, he told an audience today at the J.P. Morgan Healthcare conference in San Francisco.

"I think we’re just in the very early stages of figuring out how to best help patients with a renal denervation procedure, but there’s nothing in [Medtronic’s] announcement that dissuades us from continuing to pursue this," Starks said.

Medtronic’s highly anticipated SYMPLICITY HTN-3 clinical trial, the 1st of its kind to analyze renal denervation in a blinded, sham-controlled manner, failed to meet endpoints for efficacy in treating patients with drug-resistant hypertension. The announcement came as a shock to many, including Starks who said that he and his colleagues were still processing the news and waiting for more data.

"This was unexpected for us, to have a negative result from Medtronic’s trial, and it’s too soon for us to know what to make of that," Starks said. "It really raises far more questions than it provided answers."

Read MassDevice.com’s in-depth look at renal denervation and bias in hypertension clinical trials.

Medtronic has yet to release the bulk of the data from the trial, so it’s difficult to analyze the possible reasons that renal denervation failed to produce the types of results that many had anticipated based on previous, less-robust studies. Medtronic conducted the trial with its 1st-generation denervation technology, and it’s possible that newer systems may have done a better job, Starks mused.

"It may be that the trial was done with a technology that was too early-stage – that’s speculative on my part, but that’s among the list of questions that we have," he added. "Was the technology effective or was it that the technology was really too hard to use effectively in an expanded environment?"

There are many more questions that Starks would like answered before making a judgment on Medtronic’s trial, he said, but, meanwhile, the news has done little to dampen his enthusiasm for renal denervation and its promise in treating patients with hypertension.

Starks cited years of clinical studies supporting renal denervation, especially in treating patients whose hypertension isn’t well-controlled with drugs.

"The fact that we had and that there have been favorable early clinical results in numerous other experiences is still valid," Starks said. "There is open surgical data dating back several decades that was favorable to the impact of surgical renal denervation to treat hypertension."

St. Jude has suffered some renal denervation setbacks of its own, announcing in December that the company would halt the Enlightn IV clinical trial, just a few months after it began. The study was slated to assess nearly 600 patients, but it was halted over concerns that Medtronic’s Symplicity device would hit the market and hinder enrollment.

RSS From Medical Design & Outsourcing

  • A few ideas for improving productivity in medical processes
    Drive-based vibration and slosh control can help improve throughput in machines that assemble medical devices and products. Bipin Sen • Ed Lasch Bosch Rexroth Corporation www.boschrexroth-us.com Simply increasing the speed of a system that assembles medical devices, or packages medical products, seems like an easy way to boost throughput – until unwanted vibration (either induced […]
  • ODU announces MEDI-SNAP EMC for next generation medical applications
    ODU, announced ODU MEDI-SNAP EMC, the advanced shielded plastic connector solutions to the US market. ODU MEDI-SNAP EMC is the newest addition to ODU’s Push-Pull circular connectors. The advanced medical connector solution is lightweight, autoclavable, sterilizable and it offers a touch proofed housing and reliable EMI protection at the same time. ODU MEDI-SNAP EMC is available in […]
  • Evaluating the risk of device misconnections: Designing for medical devices with ISO 80369 in mind
    Beginning in the 1990s, concerns grew regarding the proliferation of medical devices fitted with luer connectors and the reports of patient injuries and deaths arising from misconnections. Thus began a many-years process to develop new industry standards for the small-bore connectors used in medical device applications. The much-anticipated ISO 80369 series of standards for small-bore […]
  • Custom molded filter screen assemblies limit contamination and reduce product failure
    Molded screen insert assemblies from Minnesota Rubber and Plastics are custom designed for water, beverage, off-highway and transportation applications to filter out fluid contaminants and reduce product failure. A wide range of screen options are available in many materials for difficult filtration applications allowing use with different fluids. Filter assembly orifice sizes available range from .71 […]
  • Anomet Platinum-Clad Tantalum wire designed for Implantable medical devices
    Anomet Products custom manufactures a special clad composite wire that is biocompatible, strong, and corrosion-resistant for use in fabricating implantable medical devices. Anomet Platinum-Clad Tantalum Wire combines the properties of each alloy to provide a biocompatible, high-strength, and corrosion resistant radiopaque wire for use in short-term and long-term implantable medical devices. Suitable for coils, electrodes, leads, […]
  • Finding the best way to join plastic components
    When designing an assembly method for the plastic components in a medical device, stay process-neutral and weigh the advantages and disadvantages of the available methods. As the medical device industry continues the rapid development of complex, innovative products, the need for joining plastic components is keeping pace. These requirements range from micro-scale tubes to macro […]
  • Multidisciplinary Centre for Research into Obesity opens in Sao Paulo
    Researchers, clinicians, health educators and policy makers all gathered on May 4th in Sao Paulo, Brazil, as the new Multidisciplinary Centre for Research into Obesity and Related Comorbidities (Cepid-OCRC) was opened at da Universidade Estadual de Campinas (UNICAMP). At the heart of the new facility is a 3D imaging laboratory with a Bruker PET/SPECT/CT imaging […]
  • Building lean bodies and programs at UNC Health Care
    In the healthcare industry, employees are constantly seeking ways to continuously improve and increase the quality and safety of a facility. UNC Health Care, awarded 19 times for its leadership in quality and safety, came to Magnatag for products to implement its recent lean six-sigma projects in its OB/GYN department. “I am using the Magnatag […]
  • How lifting columns improve patients’ experience
    Vertical lifts are required in a wide range of medical equipment where accessibility and comfort improves care and patient outcomes. Applications such as wheelchair lifts, examination tables, dental chairs, adjustable nurses’ stations, and optician instruments all require vertical lifts to provide appropriate care and an optimal patient experience. Designers of medical equipment need lifting columns […]
  • Patent Protection
    In today’s innovation economy, a medical device company’s success depends on the strength and value of its patent portfolio. Recent statistics from the U.S. Patent & Trademark Office (USPTO) show the issue rate for new medical device patents is exploding. In fact, the number of medical device patents issued by the USPTO has increased each […]
  • It's a sellers' market at all levels of the medtech industry
    Ken Fine, co-founder and president of Proven Process, is a popular man these days. Not a week goes by without Fine entertaining flirtations from private equity investors or potential strategic partners, looking to see if he's ready to cash out of his business after 21 years. Proven Process is a Mansfield, Mass.-based contract manufacturer providing […]

Comments

  1. says

    I simply want to tell you that I am just very new to blogging and site-building and actually loved you’re blog site. Very likely I’m planning to bookmark your blog . You surely have perfect stories. Bless you for sharing with us your web page.

Trackbacks

  1. Thank you

    Apakah anda membutuhkan obat herbal de Nature Indonesia silahkan dapat hubungi customer service kita secara langsung melalui SMS ataupun Telepon. Kami selalu online 24 jam utk melayani pembelian obat herbal de Nature.

Leave a Reply